117 related articles for article (PubMed ID: 7822785)
1. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
[TBL] [Abstract][Full Text] [Related]
2. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
[TBL] [Abstract][Full Text] [Related]
3. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ
J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
5. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
6. Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
Matsui M; Moots RJ; McMichael AJ; Frelinger JA
Hum Immunol; 1994 Oct; 41(2):160-6. PubMed ID: 7860362
[TBL] [Abstract][Full Text] [Related]
7. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
[TBL] [Abstract][Full Text] [Related]
8. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
[TBL] [Abstract][Full Text] [Related]
9. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH; Lacy E; Ridge JP
J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
[TBL] [Abstract][Full Text] [Related]
10. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Bodmer H; Ogg G; Gotch F; McMichael A
Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
[TBL] [Abstract][Full Text] [Related]
11. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
[TBL] [Abstract][Full Text] [Related]
13. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
14. Specificity of peptide binding by the HLA-A2.1 molecule.
Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
[TBL] [Abstract][Full Text] [Related]
15. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
Martinon F; Gomard E; Hannoun C; Lévy JP
Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
[TBL] [Abstract][Full Text] [Related]
16. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ
J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
Tussey LG; Matsui M; Rowland-Jones S; Warburton R; Frelinger JA; McMichael A
J Immunol; 1994 Feb; 152(3):1213-21. PubMed ID: 8301126
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides.
Nijman HW; Houbiers JG; van der Burg SH; Vierboom MP; Kenemans P; Kast WM; Melief CJ
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):121-6. PubMed ID: 7506574
[TBL] [Abstract][Full Text] [Related]
19. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
Man S; Ridge JP; Engelhard VH
J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
[TBL] [Abstract][Full Text] [Related]
20. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
Utz U; Koenig S; Coligan JE; Biddison WE
J Immunol; 1992 Jul; 149(1):214-21. PubMed ID: 1607654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
